These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8991348)

  • 61. Treatment of scabies using 8% and 10% topical sulfur ointment in different regimens of application.
    Sharquie KE; Al-Rawi JR; Noaimi AA; Al-Hassany HM
    J Drugs Dermatol; 2012 Mar; 11(3):357-64. PubMed ID: 22395587
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topical treatment modalities for old world cutaneous leishmaniasis: a review.
    Alavi-Naini R; Fazaeli A; O'Dempsey T
    Prague Med Rep; 2012; 113(2):105-18. PubMed ID: 22691282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topical treatment for cutaneous leishmaniasis.
    Garnier T; Croft SL
    Curr Opin Investig Drugs; 2002 Apr; 3(4):538-44. PubMed ID: 12090720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.
    Sundar S; Agrawal N; Arora R; Agarwal D; Rai M; Chakravarty J
    Clin Infect Dis; 2009 Sep; 49(6):914-8. PubMed ID: 19663597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluconazole for the treatment of cutaneous leishmaniasis.
    Zvulunov A; Klaus S; Vardy D
    N Engl J Med; 2002 Aug; 347(5):370-1; author reply 370-1. PubMed ID: 12151480
    [No Abstract]   [Full Text] [Related]  

  • 66. Efficacy and safety of paromomycin for treating amebiasis in Japan.
    Kikuchi T; Koga M; Shimizu S; Miura T; Maruyama H; Kimura M
    Parasitol Int; 2013 Dec; 62(6):497-501. PubMed ID: 23850836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute renal failure in four cats treated with paromomycin.
    Gookin JL; Riviere JE; Gilger BC; Papich MG
    J Am Vet Med Assoc; 1999 Dec; 215(12):1821-3, 1806. PubMed ID: 10613215
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J; Bukhari I; Jamshid M; Bashir S; Masoom Yasinzai M; Anwar M
    East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of Dientamoeba fragilis infection with paromomycin.
    Vandenberg O; Souayah H; Mouchet F; Dediste A; van Gool T
    Pediatr Infect Dis J; 2007 Jan; 26(1):88-90. PubMed ID: 17195717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation, characterization, and topical delivery of paromomycin ion pairing.
    Nogueira IR; Carneiro G; Yoshida MI; de Oliveira RB; Ferreira LA
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1083-9. PubMed ID: 21449697
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cutaneous leishmaniasis on an unusual site--the glans penis.
    Grunwald MH; Amichai B; Trau H
    Br J Urol; 1998 Dec; 82(6):928. PubMed ID: 9883247
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
    BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.
    Hewitt RG; Yiannoutsos CT; Higgs ES; Carey JT; Geiseler PJ; Soave R; Rosenberg R; Vazquez GJ; Wheat LJ; Fass RJ; Antoninievic Z; Walawander AL; Flanigan TP; Bender JF
    Clin Infect Dis; 2000 Oct; 31(4):1084-92. PubMed ID: 11049793
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
    Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cutaneous leishmaniasis.
    Bailey MS; Lockwood DN
    Clin Dermatol; 2007; 25(2):203-11. PubMed ID: 17350500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Topical treatment of cutaneous leishmaniasis.
    el-On J; Livshin R; Paz ZE; Weinrauch L
    Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1280-1. PubMed ID: 3933633
    [No Abstract]   [Full Text] [Related]  

  • 77. Salvage therapy with Sodium chlorosum (formerly DAC N-055) for cases of refractory lupoid cutaneous leishmaniasis: results from a compassionate use study with 0.09% Sodium chlorosum in amphiphilic basic cream.
    Molkara S; Poursoltani E; Stahl KW; Maleki M; Khamesipour A; Bogdan C; Salehi M; Goyonlo VM
    BMC Infect Dis; 2019 Nov; 19(1):1005. PubMed ID: 31779597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.
    Mouri O; Melenotte C; Guéry R; Cotteret C; Schweitzer-Chaput A; Perignon A; Thellier M; Bourrat E; Kaguelidou F; Siriez JY; Malvy D; Gangneux JP; Duvignaud A; Ravel C; Cisternino S; Ransom J; Caumes E; Lortholary O; Grogl M; Buffet P
    PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011492. PubMed ID: 37561802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leishmania tropica in children: a retrospective study.
    Solomon M; Schwartz E; Pavlotsky F; Sakka N; Barzilai A; Greenberger S
    J Am Acad Dermatol; 2014 Aug; 71(2):271-7. PubMed ID: 24775403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
    El-On J; Witztum A; Schnur LF
    Infect Immun; 1986 Feb; 51(2):704-6. PubMed ID: 3943909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.